Skip to main content
. 2022 Dec 9;13:974468. doi: 10.3389/fphar.2022.974468

FIGURE 10.

FIGURE 10

Combination effect of OP-D and 5-FU or doxorubicin in HCT116p53+/+ cells. (A) HCT116p53+/+ cells were treated with or without OP-D (20 or 40 μM) and 5-FU (10 μM) for 24 h. (B) HCT116p53+/+ cells were treated with or without OP-D (20 or 40 μM) and doxorubicin (0.3 μM) for 24 h. (C) Then, cells were collected and performed by Western blotting with various antibodies. (D) Then, cells were collected and performed by Western blotting with various antibodies. Data represent means ± SD. **p < 0.01, ***p < 0.005, ****p < 0.001, ##p < 0.01, ###p < 0.005, ####p < 0.001.